Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial

Authors: Tanasatitchai, Chanikan, Amphol, Supamat, Nantawong, Ladda, Sangchan, Prangrawee, Sinkajarern, Varissara, Phoonakh, Thutpharritchn, Utenpattanun, Phornnapat, Sithu Shein, Aye Mya, Vitoonpong, Timporn, Chongthavonsatit, Nichapha, Mankong, Yahya, Chaichana, Piyapong, Yaithet, Jenjira, Pongprajak, Dumrongsak, Traimuangpak, Sukjai, Saksirisampant, Gasit, Lamloeskittinon, Phimonsiri, Hamdy, Adam Adam, Kosasih, Sinthu Sinthu, Luk-in, Sirirat Sirirat, Wannigama, Dhammika Leshan ^{a, b, c, d, e, f, at, ∗∗}, Hurst, Cameron ^{g, au}, Phattharapornjaroen, Phatthranit ^{h, i, ∗∗∗}, Hongsing, Parichart ^{j, k, au}, Sirichumroonwit, Natchalaikorn ^{l, au}, Chanpiwat, Kanokpoj ^{m, ∗∗∗∗}, Rad S.M., Ali Hosseini ^{n, o, au}, Storer, Robin James ^p, Ounjai, Puey ^q, Kanthawee, Phitsanuruk ^r, Ngamwongsatit, Natharin ^s, Kupwiwat, Rosalyn ^t, Kupwiwat, Chaisit ^u, Brimson, James Michael ^v, Devanga Ragupathi, Naveen Kumar ^{e, w, x}, Charuluxananan, Somrat ^y, Leelahavanichkul, Asada ^{b, z}, Kanjanabuch, Talerngsak ^{aa, ab, ac, ad}, Higgins, Paul G. ^{ae, af, ag}, Badavath, Vishnu Nayak ^ah, Amarasiri, Mohan ^ai, Verhasselt, Valerie ^{aj, ak, au}, Kicic, Anthony ^{al, am, an, ao}, Chatsuwan, Tanittha ^{b, c, ∗∗∗∗∗∗}, Pirzada, Kashif ^{ap, aq, ∗}, Jalali, Farid ^{ar, au, ∗∗∗∗∗}, Reiersen, Angela M. ^{as, au, ∗∗∗∗∗∗∗∗}, Abe, Shuichi ^{a, ∗∗∗∗∗∗∗}, Ishikawa, Hitoshi ^at

Source: In eClinicalMedicine April 2024 70